MHRA-2022-0088-V188
Type II variation for application MHRA-2022-0088. Type II variation: Shelf Life Extension for Alzabistat — critical change
Variation Number
MHRA-2022-0088-V188
Type
Type II
Application
Change
Status
Blocked
Fee
€33,337
Submitted
2022-12-01
Approved
—
Description
Type II variation: Shelf Life Extension for Alzabistat — critical change